Current Research Studies

A Phase 3, Multicenter, Prospective, Randomized, Open-label Efficacy and Safety Study of Intravenous Brincidofovir versus Intravenous Cidofovir for Treatment of Adenovirus Infection in Pediatric and Adult Subjects After Allogeneic Hematopoietic Cell Transplantation (allo-HCT)

SymBio_BCV_PA02

  • Condition(s): Other
  • Phase: III
  • Clinicaltrials.gov ID: NCT07387367

What is the goal of the study?

This Phase 3, multi-center, global, randomized, open-label study will assess efficacy of IV BCV, compared to IV CDV, in subjects after allo-HCT with AdV viremia.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: